Respiri Ltd. appointed Mark Ziirsen and Brendan Mason to its board, replacing Leon L'Huillier and John Ribot-de-Bresac who are retiring.
Ziirsen is a nonexecutive director at SmartTrans Holdings Ltd. He served as Admedus Ltd.'s CFO as well as Cochlear Ltd.'s director of finance and IT for Asia Pacific in the past.
Mason is the CEO and managing director of SmartTrans. He served as Cochlear's general manager from 2007 to 2014.
Australia-based Respiri develops medical devices and mobile health applications.
